Blog
GUEST POST: NorthStar VETS Uses TANOVEA-CA1 for Canine Lymphoma Patients
Have You Considered Pet Insurance? A Brief Overview.
Guest Blog: Helping Your Beloved Canine Fight Cancer
Guest Blog: Understanding Canine Cancer & Coping With This Deadly Disease
New Year, New Focus on Food Safety for Your Dog
(Video) VCS Interview with Dr. Andrew Novosad
November TANOVEA®-CA1 Webinar Vlog – Anticipating and Addressing Adverse Effects
Cancer Treatment for Dogs and How Dogs Improve Our Health
VetDC Announces New TANOVEA®-CA1 Publication, State of the Art Presentation at VCS 2017 Annual Conference
FORT COLLINS, Colo.–(BUSINESS WIRE)–VetDC, Inc., the leading veterinary cancer therapeutics company, today announced a new TANOVEA®-CA1 (rabacfosadine for injection) publication in Veterinary & Comparative Oncology. Data from this publication and several new VetDC-sponsored studies was prominently featured in a State …